New research suggests ibuprofen, an anti-inflammatory drug sold under brand names including Advil and Motrin, may lower the risk for /*Parkinson's disease*/.
In a study, experts found that after six years people who took ibuprofen twice or three times a week were 38 percent less likely to develop Parkinson's than those who had not taken it.
The potential benefit was only found with ibuprofen, not aspirin or naproxen.
